v3.26.3
Revenue
 9 Months Ended
Sep. 30, 2026
Revenue from Contract with Customer [Abstract]  
Revenue Revenue
The following table presents our revenue disaggregated by source, which also have similar economic characteristics (in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
Create Solutions$165,070 $152,359 $479,335 $456,519 
Grow Solutions457,022 318,256 1,197,463 890,040 
Total revenue$622,092 $470,615 $1,676,798 $1,346,559 
The following table presents our revenue disaggregated by geography, based on the invoice address of our customers (in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
United States$144,463 $130,741 $428,656 $379,396 
Greater China (1)
157,444 90,458 372,573 239,235 
EMEA (2)
184,715 147,953 508,659 441,262 
APAC (3)
122,528 89,359 330,807 252,735 
Other Americas (4)
12,942 12,104 36,103 33,931 
Total revenue$622,092 $470,615 $1,676,798 $1,346,559 
(1)    Greater China includes China, Hong Kong, and Taiwan.
(2)    Europe, the Middle East, and Africa ("EMEA")
(3)    Asia-Pacific, excluding Greater China ("APAC")
(4)    Canada and Latin America ("Other Americas")
Accounts Receivable, Net
Accounts receivable are recorded at the original invoiced amount, net of allowances for uncollectible amounts. We estimate losses on uncollectible amounts based on expected losses, including our historical experience of actual losses. The estimated losses on uncollectible amounts are recorded in general and administrative expense on our condensed consolidated statements of operations. As of
September 30, 2026 and December 31, 2025, the allowance for uncollectible amounts was $9.3 million and $10.9 million, respectively.
Sales Commissions
Sales commissions that have a benefit beyond one year are capitalized and amortized on a straight-line method over the expected period of benefit, which is generally three years. As of September 30, 2026, capitalized commissions, net of amortization, included in prepaid expenses and other and other assets were $3.7 million and $1.8 million, respectively. As of December 31, 2025, capitalized commissions, net of amortization, included in prepaid expenses and other and other assets were $5.4 million and $2.8 million, respectively.
During the three and nine months ended September 30, 2026, we recorded amortization costs of $1.5 million and $4.7 million, respectively, in sales and marketing expenses, as compared to $1.7 million and $5.5 million during the three and nine months ended September 30, 2025, respectively. We did not incur any impairment losses for the three and nine months ended September 30, 2026 and 2025.
Contract Balances and Remaining Performance Obligations
Contract assets (unbilled receivables), primarily included in accounts receivable, net, are recorded when revenue is earned in advance of customer billing schedules. Unbilled receivables totaled $16.8 million and $15.8 million as of September 30, 2026 and December 31, 2025, respectively. The long term portion of those unbilled receivables was included in other long-term assets on our consolidated balance sheets, and was not material as of September 30, 2026 and December 31, 2025.
Contract liabilities (deferred revenue) relate to payments received in advance of performance under the contract. Revenue recognized during the nine months ended September 30, 2026 that was included in the deferred revenue balances at January 1, 2026 was $200 million.
Additionally, we have performance obligations associated with commitments in customer contracts to perform in the future that had not yet been recognized in our consolidated financial statements. For contracts with original terms that exceed one year, those commitments not yet recognized as of September 30, 2026, were $597 million and relate primarily to Create Solutions subscriptions, Enterprise Support, and Strategic Partnerships. These commitments generally extend over the next one to five years and we expect to recognize approximately $292 million or 49% of this revenue during the next 12 months.